He was randomly assigned to receive everolimus, a type of chemotherapy drug, in a clinical trial, which is used to treat ...

Palbociclib is ready to go in dose expansion at full dose of 125 mg. Everolimus, the RP2D [recommended phase II dose] is 7.5 milligrams of everolimus with full dose elacestrant, and so that's also ...

ADELA, an international phase III study being conducted across multiple countries, combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations, aiming to ...